Preliminary Finding of No Significant Impact (Fonsi) for Aquadvantage Salmon

Preliminary Finding of No Significant Impact (Fonsi) for Aquadvantage Salmon is a 6-page legal document that was released by the U.S. Department of Health and Human Services - U.S. Food and Drug Administration on May 4, 2012 and used nation-wide.

FAQ

Q: What is the Preliminary Finding of No Significant Impact (FONSI)?
A: The Preliminary Finding of No Significant Impact (FONSI) is a determination that a proposed action, in this case AquAdvantage Salmon, is unlikely to result in significant environmental impacts.

Q: What is AquAdvantage Salmon?
A: AquAdvantage Salmon is a genetically engineered salmon produced by AquaBounty Technologies. It is designed to grow faster than conventional salmon.

Q: What does a FONSI mean for AquAdvantage Salmon?
A: A FONSI means that the environmental impact of AquAdvantage Salmon is not significant, according to the preliminary findings.

Q: Who made the FONSI determination for AquAdvantage Salmon?
A: The FONSI determination for AquAdvantage Salmon was made by the U.S. Food and Drug Administration (FDA).

Q: What are the potential benefits of AquAdvantage Salmon?
A: The potential benefits of AquAdvantage Salmon include increased production efficiency, reduced pressure on wild fish populations, and improved food security.

Q: Are there any concerns about AquAdvantage Salmon?
A: Yes, there are concerns about potential environmental risks, genetic contamination of wild salmon populations, and consumer acceptance of genetically engineered food.

Q: Is AquAdvantage Salmon approved for commercialization?
A: AquAdvantage Salmon has received regulatory approval in the United States and Canada for commercial production and sale.